Yamada Jun, Sugimoto Yumi, Ujikawa Masanori, Goko Hideki, Yagura Tatsuo
Department of Pharmacology, Kobe Pharmaceutical University, Motoyamakita-machi, Higashinada, Kobe 658-8558, Japan.
Life Sci. 2003 Sep 19;73(18):2335-44. doi: 10.1016/s0024-3205(03)00641-6.
Mechanisms for hyperleptinemia elicited by a serotonin (5-hydroxytryptamine, 5-HT) precursor, 5-hydroxytryptophan (5-HTP), were investigated. 5-HTP elicited apparent increases in serum leptin levels of mice. Administration of 5-HTP did not alter expression of leptin mRNA in white adipose tissues. Furthermore, neither 5-HTP nor 5-HT increased leptin secretion from isolated fat pads of mice. Since insulin is known to enhance leptin release, involvement of insulin in 5-HTP-induced hyperleptinemia was examined. 5-HTP significantly elevated serum insulin levels. In mice treated with streptozotocin, which depletes insulin, 5-HTP did not increase serum leptin levels. These results suggest that hyperinsulinemia participates the elevation of serum leptin levels elicited by 5-HTP.